ATE439136T1 - Verfahren zur behandlung von halitose - Google Patents
Verfahren zur behandlung von halitoseInfo
- Publication number
- ATE439136T1 ATE439136T1 AT02779021T AT02779021T ATE439136T1 AT E439136 T1 ATE439136 T1 AT E439136T1 AT 02779021 T AT02779021 T AT 02779021T AT 02779021 T AT02779021 T AT 02779021T AT E439136 T1 ATE439136 T1 AT E439136T1
- Authority
- AT
- Austria
- Prior art keywords
- treating
- halitose
- vertebrate
- halitosis
- bismuth
- Prior art date
Links
- 206010006326 Breath odour Diseases 0.000 title abstract 3
- 208000032139 Halitosis Diseases 0.000 abstract 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 150000001621 bismuth Chemical class 0.000 abstract 1
- 229910052797 bismuth Inorganic materials 0.000 abstract 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPR9161A AUPR916101A0 (en) | 2001-11-28 | 2001-11-28 | Method of treating halitosis |
| PCT/AU2002/001604 WO2003045403A1 (en) | 2001-11-28 | 2002-11-27 | Method of treating halitosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE439136T1 true ATE439136T1 (de) | 2009-08-15 |
Family
ID=3832971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02779021T ATE439136T1 (de) | 2001-11-28 | 2002-11-27 | Verfahren zur behandlung von halitose |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050053556A1 (de) |
| EP (1) | EP1469867B1 (de) |
| AT (1) | ATE439136T1 (de) |
| AU (1) | AUPR916101A0 (de) |
| DE (1) | DE60233353D1 (de) |
| NZ (1) | NZ533677A (de) |
| WO (1) | WO2003045403A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7544204B2 (en) * | 2003-10-15 | 2009-06-09 | Valam Corporation | Control of halitosis-generating and other microorganisms in the non-dental upper respiratory tract |
| CN114984254B (zh) * | 2022-06-08 | 2023-06-27 | 上海交通大学医学院附属第九人民医院 | 一种光声成像造影剂及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6902738B2 (en) * | 1994-05-02 | 2005-06-07 | Josman Laboratories, Inc. | Topical oral dosage forms containing bismuth compounds |
| US5834002A (en) * | 1994-05-02 | 1998-11-10 | Josman Laboratories, Inc. | Chewing gum containing colloidal bismuth subcitrate |
| US6372784B1 (en) * | 1995-02-07 | 2002-04-16 | Josman Laboratories, Inc. | Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds |
| US6379651B1 (en) * | 1995-02-07 | 2002-04-30 | Josman Laboratories | Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases |
| EP0879035B1 (de) * | 1995-08-24 | 2006-06-14 | Josman Laboratories, Inc. | Bismut enthaltende arzneimittel in topischen darreichungsformen |
| CN101022826A (zh) * | 2004-06-07 | 2007-08-22 | 哈罗尔·戴维·贡 | 用于癌症治疗的细菌组合物 |
-
2001
- 2001-11-28 AU AUPR9161A patent/AUPR916101A0/en not_active Abandoned
-
2002
- 2002-11-27 AT AT02779021T patent/ATE439136T1/de not_active IP Right Cessation
- 2002-11-27 US US10/497,272 patent/US20050053556A1/en not_active Abandoned
- 2002-11-27 EP EP02779021A patent/EP1469867B1/de not_active Expired - Lifetime
- 2002-11-27 DE DE60233353T patent/DE60233353D1/de not_active Expired - Lifetime
- 2002-11-27 NZ NZ533677A patent/NZ533677A/en not_active IP Right Cessation
- 2002-11-27 WO PCT/AU2002/001604 patent/WO2003045403A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE60233353D1 (de) | 2009-09-24 |
| US20050053556A1 (en) | 2005-03-10 |
| AUPR916101A0 (en) | 2001-12-20 |
| EP1469867A4 (de) | 2005-10-05 |
| EP1469867A1 (de) | 2004-10-27 |
| EP1469867B1 (de) | 2009-08-12 |
| WO2003045403A1 (en) | 2003-06-05 |
| NZ533677A (en) | 2006-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60335997D1 (de) | Lactoferrin-zusammensetzungen und verfahren zur behandlung von diabetischen ulcus | |
| ATE489102T1 (de) | Verwendung von botulinum toxin zur behandlung von durch infektion verursachtem schmerz | |
| BR9502707A (pt) | Composto composição farmacêutica e método para o tratamento de uma afecção | |
| ATE377657T1 (de) | Serpin-arzneistoffe zur behandlung einer hiv- infektion und verfahren zu deren verwendung | |
| ATE493433T1 (de) | Neue zusammensetzung und verfahren zur behandlung von immunerkrankungen | |
| ATE399782T1 (de) | Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen | |
| DE60034871D1 (de) | Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust | |
| ATE331527T1 (de) | Verfahren zur behandlung von brustdrüsenerkrankungen | |
| ATE415962T1 (de) | Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs | |
| ATE346614T1 (de) | Vaginale zusammensetzung enthaltend lidocaine zur behandlung von gebärmutterrhythmusstörung | |
| DE60114439D1 (de) | Verfahren zur antimikrobiellen behandlung von fasermaterialien | |
| ATE356995T1 (de) | Verfahren zur identifizierung von mitteln zur behandlung von diabetes | |
| DE602004028574D1 (de) | Zusammensetzungen und verfahren zur behandlung des reizdarmsyndroms und von nichtulzeröser dyspepsie | |
| ATE359808T1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
| DE69913380D1 (de) | Zusammensetzung zur behandlung von periodontalen erkrankungen | |
| DE60233353D1 (de) | Verfahren zur behandlung von halitose | |
| ATE344662T1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
| ATE251462T1 (de) | Verfahren zur behandlung von narbengewebe | |
| EP1056458A4 (de) | Methoden zur behandlung von schmerzen, einscliesslich chronischen und frauenspezifischen schmerzen | |
| ATE453386T1 (de) | Polyamin-verbindungen zur behandlung von chemokin-rezeptor-vermittelten krankheiten | |
| ATE203162T1 (de) | Verfahren zur behandlung von chronischer prostatitis mit 17-beta-n-tertbutylcarbamoyl-4- aza-5 alpha-androst-1-en-3-one | |
| DE60020729D1 (de) | Verfahren und zusammensetzung zur behandlung von adenovirale augeninfektionen | |
| ATE236633T1 (de) | Topische verwendung von loperamid zur behandlung mikrobieller infektionen | |
| DE60033569D1 (de) | Neue verwendung von prodigiosin zur behandlung von diabetes mellitus | |
| DE69504717D1 (de) | Behandlung von organischen Verbindungen zur Reduzierung des Chlorgehaltes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |